Financial News

Moderna Downgraded To Neutral From Overweight At Piper Sandler

Piper Sandler analyst Edward Tenthoff downgraded Moderna to Neutral from Overweight with a price target of $445, up from $246, post the Q2 results.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback